Search
for
Sort by
Research 61–90 of 110
- Alopecia areata: A multifactorial autoimmune condition
- Current and future pharmacotherapy for alopecia areata
- Transcriptomic characterization of Lonrf1 at the single-cell level under pathophysiological conditions
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a
- Cutaneous reactions to recombinant cytokine therapy
- British Cosmetic Dermatology Group
- Skin involvement in systemic lupus erythematosus: a review article
- Discoid Lupus Erythematosus
- Wound Healing: A Cellular Perspective
- Mechanisms regulating skin immunity and inflammation
- An Overview of Alopecias
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Immunological control of skin development: from homeostasis to developmental pathologies
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Primary cicatricial alopecia: Recent advances in understanding and management
- The role of diet in the management of psoriasis: a scoping review
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Drug eruptions in dermatology
- Human placenta hydrolysates: from V.P. Filatov to the present day: Review
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Acne and acneiform eruptions
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Efficacy of tofacitinib in pediatric alopecia universalis